The HIV Education Prison ProjectImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
click here to return to HEPP main menu


Meeting Update: Society of Correctional Physicians (SCP) Baltimore, Maryland, April 10, 2003

Joseph Paris *, M.D., Medical Director, Georgia Department of Corrections
HIV Education Prison Project: Volume 6, Number 5 - May 2003

The Society of Correctional Physicians (SCP) held its semiannual meeting in Baltimore, Maryland, on April 10. The theme, Correctional Care of Infectious Diseases and Mental Health Issues, attracted experts willing to share recent developments with the audience of correctional physicians. In the field of infectious disorders, contributions were given by Drs. David Williamson of the C. T. Perkins Hospital Center, David L. Thomas of Johns Hopkins, Jay Hoofnagle of the National Institutes of Health, Glenn Treisman of Johns Hopkins, and others.

Dr. Thomas emphasized the importance of HBeAg testing of all patients with chronic hepatitis B virus (HBV). Patients with negative HBeAg tests and normal ALT levels are "healthy carriers," he said. Indications for interferon treatment include persistently elevated ALT levels (over twice the normal level), abnormal liver histology, and absence of end-stage liver disease. Sustained responders ("cures") will have no evidence of HBeAg, will show corresponding antibodies (Anti-HBe), and ALT normalization.

Dr. Hoofnagle described a new understanding of the natural history of chronic hepatitis C (HCV) infection. In the absence of HIV coinfection, HCV may take up to 50 years to evolve into fatal end-stage liver disease or hepatocellular carcinoma (HCC). HCV progression is marked by development of liver fibrosis, as measured by Stages 1-4 liver histology. Because therapies are constantly being improved, Hoofnagle stated that it might be prudent to wait for better therapies for patients with early stages of fibrosis. Otherwise, he said, a treatment failure may result and patients may not respond to retreatment with future therapies. Dr. Hoofnagle also showed his recent compilation of end-of-follow-up "cure" results for white and African American persons. Although the number of African American patients treated was small, a disturbing and unexplained lowered response rate was noted. The significance of this difference is not yet known.

Dr. Williamson described common psychiatric complications of HIV disease. He distinguished patients who can be safely treated by primary care physicians from those who may need psychiatric evaluation and follow-up. Lastly, Dr. Treisman reviewed mental health approaches to patients with HIV infection and other conditions. He emphasized the difficulty for psychiatrists to understand the motivations and social situation of the inmates that they treat. These barriers may result in a relative inability to achieve substantial patient rapport and therefore, less success in helping these patients.

* Nothing to disclose

030501
HEPP2003-0502


©1997,1998,1999,2000,2001,2002, 2003. The recently formed HIV Education Prison Project (HEPP) is a medical education program that targets a growing population, inmates in correctional facilities, that has been underserved in HIV care. It is part of the Brown University AIDS Program. Permission to use and reproduce portions of this newsletter is hereby granted provided that author and publication are fully credited and both copyright and permission notice appear with reprinted material. Inquiries may be directed to heppnews@brown.edu. Website: HIV Education Prison Project.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.